- Home
- JYD vs DYAI Comparison
JYD vs DYAI Comparison
Compare JYD & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JYD | DYAI |
|---|---|---|
| Founded | 2001 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2M | 32.5M |
| IPO Year | 2022 | 2003 |
Fundamental Metrics
Financial Performance| Metric | JYD | DYAI |
|---|---|---|
| Price | $0.80 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 784.2K | 67.7K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.12 | $0.65 |
| 52 Week High | $6.85 | $1.35 |
Technical Indicators
Market Signals| Indicator | JYD | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 25.64 | 48.92 |
| Support Level | $0.12 | $0.71 |
| Resistance Level | $3.01 | $0.97 |
| Average True Range (ATR) | 0.67 | 0.05 |
| MACD | -0.56 | 0.00 |
| Stochastic Oscillator | 5.87 | 69.62 |
Price Performance
Historical ComparisonAbout JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, fragmented logistics, and chartered airline freight services, supply chain management, and other value-added services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.